Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (351.466)

61

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block : Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

enthalten in: ClinicalTrials.gov | 2024

62

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) : Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)

enthalten in: ClinicalTrials.gov | 2024

63

Oral Supplementation Compared With Hyaluronic Acid Infiltration in Rotator Cuff Tendinopathies : Efficacy of Oral Hyaluronic Acid and Collagen Supplementation Compared With Hyaluronic Acid Infiltration Treatment in Rotator Cuff Tendinopathies: A Prospective Study

enthalten in: ClinicalTrials.gov | 2024

64

High Flow Nasal Cannula Rates in Pediatric Asthma : High Flow Nasal Cannula Rates in Pediatric Asthma Exacerbations: A Feasibility Study

enthalten in: ClinicalTrials.gov | 2024

65

Risk of Aspergillus Infection in Patients With Chronic Lung Disease : Risk of Aspergillus Infection in Patients With Chronic Structural Lung Disease

enthalten in: ClinicalTrials.gov | 2024

66

Impact of Clinical Pharmacist Practitioner Management of Chronic Obstructive Pulmonary Disease in the Ambulatory Care Setting

enthalten in: Journal of pharmacy practice | 2024

von Haddon, A. | Gross, K. | Mozes, C.

67

Early Versus Late Use of Vedolizumab in Ulcerative Colitis : Clinical, Endoscopic, and Histological Outcomes

enthalten in: Journal of Crohn's & colitis | 2024

von Vermeire, S. | Hanzel, J. | Löwenberg, M. | +38

68

Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary

enthalten in: Ophthalmology and therapy | 2024

von Tóth, G. | Lukács, A. | Stachon, T. | +4

69

Jian Y, Chang L, Shi M-X, et al. Pomalidomide, bortezomib, and dexamethasone for newly diagnosed multiple myeloma patients with renal impairment. Blood Adv. 2023;7(24):7581-7584

enthalten in: Blood advances | 2024

ErratumFor: Blood Adv. 2023 Dec 26;7(24):7581-7584. - PMID 37922425

70

Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long-term adverse outcomes in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Fernández-Clotet, A. | Ordás, I. | Masamunt, M. | +8